Le Lézard
Classified in: Health
Subject: PER

Lianping Weng M.D., Joins The Oncology Institute of Hope and Innovation

CERRITOS, Calif., Jan. 24, 2020 /PRNewswire-PRWeb/ -- The Oncology Institute of Hope and Innovation welcomes Lianping Weng M.D., to their team of specialists.

Dr. Liangping Weng graduated with his Doctor of Medicine from Wannan Medical College in Wuhu, Anhui, China. He completed his residency in Internal Medicine from Mount Vernon Hospital in New York and his fellowship in Hematology/Oncology from Boston Medical Center in Boston Massachusetts. Dr. Weng has multiple publications and had participated in several research projects.

Dr. Liangping Weng is a dedicated physician who believes the most important aspect of cancer treatment is compassion and education. He strives to communicate efficiently with his patients and their loved ones. He enjoys getting to know his patients and their families and remains active in research and clinical studies.


SOURCE The Oncology Institute of Hope and Innovation

These press releases may also interest you

18 fév 2020
Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help streamline...

18 fév 2020
Biotech Institute, LLC, the global leader in hemp and cannabis plant breeding, science, and innovation, and Booshoot, LLC ("Booshoot") announced today that they have finalized a groundbreaking technology licensing agreement that will set a new...

18 fév 2020
UBM BN Co., Ltd., the fair manager of SECON 2020 originally scheduled for 18 - 20 March 2020 has made the decision to reschedule the event to 6 - 8 July at KINTEX, Korea.   The decision is taken after careful consideration and close consultations...

18 fév 2020
Nanalysis Scientific Corp. ("Nanalysis", TSXV:NSCI) is pleased to announce that it won the award for 'Best New Analytical Product' at the recent Nanotech Exhibition and Conference in Tokyo, Japan. Nanalysis was the only small-cap, non-Japanese...

18 fév 2020
Vanda Pharmaceuticals Inc. (Vanda) today announced it will release results for the fourth quarter and full year 2019 on Tuesday, February 25, 2020, after the market closes.   Vanda will host a conference call at 4:30 PM ET on Tuesday, February 25,...

18 fév 2020
Gilead Sciences, Inc. today announced that Johanna Mercier, Chief Commercial Officer, and Merdad Parsey, MD, PhD, Chief Medical Officer, will participate in a fireside chat at the Cowen and Company 40th Annual Health Care Conference in Boston on...

News published on 24 january 2020 at 09:00 and distributed by: